Results 111 to 120 of about 25,505 (239)

In vivo evidence for NMDA receptor mediated excitotoxicity in a murine genetic model of Huntington Disease

open access: yes, 2008
N-methyl-D-aspartate receptor (NMDAR) mediated excitotoxicity is implicated as a proximate cause of neurodegeneration in Huntington Disease (HD). However, this hypothesis has not been tested rigorously in vivo. NMDAR NR2B-subunits are the predominant NR2
Joe Tsien   +4 more
core  

ROS-Specific Huntingtin Interactions: Huntingtin chromatin retention dynamics by FRAP with veliparib

open access: yes, 2019
<p>Measurement of huntingtin chromatin recruitment dynamics by fluorescence recovery after photobleaching (FRAP) of the YFP-tagged huntingtin-specific intrabody, nucHCB2, under conditions of oxidative stress and PARP inhibition</p>This ...
Maiuri, Tamara   +3 more
core   +1 more source

NEURAL ROSETTES FORMATION AS A NEWLY EMERGENT HUNTINGTIN FUNCTION [PDF]

open access: yes, 2010
Huntingtin is a large, ubiquitous, partially unknown protein, in which mutation in its N-terminus is the cause of genetic, neurodegenerative disease called Huntington Disease.
V. LO SARDO
core   +1 more source

Exploring and Targeting the Connection of Iron and Copper Homeostasis to Neurodegenerative Diseases

open access: yesMedComm, Volume 7, Issue 6, June 2026.
Iron and copper dyshomeostasis, along with their interactions with key intrinsically disordered proteins (e.g., Aβ, tau, α‐synuclein) have a strong implication in the onset and progression of neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), Prion diseases (PrDs), Huntington's disease (HD), Wilson's disease (WD),
Xin Liu   +9 more
wiley   +1 more source

Targeting Mitochondria in Aging‐Related Diseases: Therapeutic Potential and Obstacles

open access: yesMedComm, Volume 7, Issue 6, June 2026.
This article systematically summarized the specific mechanism of aging‐related diseases caused by mitochondrial dysfunction, and summarized the broad‐spectrum treatment methods and disease targeted treatment strategies for mitochondria. At the same time, it also pointed out the dilemma faced by mitochondrial targeted treatment.
Zijie Xiang   +12 more
wiley   +1 more source

Transcriptional Regulation of the Huntingtin Gene

open access: yesJournal of Huntington's Disease, 2018
Huntington’s disease (HD) is an autosomal dominant neurodegenerative disorder caused by a CAG trinucleotide expansion in the HTT gene, which encodes for an abnormal polyglutamine tract in the huntingtin protein (HTT). This review examines the known mechanisms of HTT gene regulation.
Thomson, Sarah B., Leavitt, Blair R.
openaire   +3 more sources

The huntingtin protein in Huntington disease

open access: yes, 2017
Huntingtin disease (HD) is an autosomal dominant inheritable disease that mainly affects the brain. HD is caused by expansion of a CAG repeat within exon 1 of the huntingtin gene giving rise to the expression of a mutant huntingtin protein with an ...
Schut, M.H.
core  

Pathways of Protein Secretion in Prokaryotes and Eukaryotes: Molecular Mechanisms, Biological Functions, and Therapeutic Opportunities

open access: yesMedComm, Volume 7, Issue 6, June 2026.
This graphical abstract delineates noncanonical protein secretion systems across eukaryotes and prokaryotes. Eukaryotic UcPS covers four ER–Golgi bypass pathways, enabling rapid leaderless protein export via direct transmembrane translocation or vesicle‐mediated release.
Qiyuan Yang   +8 more
wiley   +1 more source

Partial characterisation of murine huntingtin and apparent variations in the subcellular localisation of huntingtin in human, mouse and rat brain

open access: yes, 1996
Huntington's disease (HD) is an inherited neurodegenerative disorder caused by the expansion of a CAG repeat in a gene coding for a protein of unknown function.
Wood, J. D.   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy